https://www.businesswire.com/news/home/20251203872467/en/Owkin-Announces-International-Validation-Results-of-BRCAura-AI-Driven-Screening-for-gBRCA-Mutations-Directly-From-Pathology-Slides
Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA...
Owkin shares promising validation results for BRCAura RUO, a clinical-grade research-use-only AI product designed to screen for germline BRCA1/2 mutations (g...